CSMCX vs. NCLEX
CSMCX (Congress Small Cap Growth Fund) and NCLEX (Nicholas Limited Edition Fund) are both Small Cap Growth Equities funds. Over the past 10 years, CSMCX returned 16.31%/yr vs 7.68%/yr for NCLEX. Their correlation of 0.90 means they have usually moved in the same direction. CSMCX charges 1.00%/yr vs 0.85%/yr for NCLEX.
Performance
CSMCX vs. NCLEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CSMCX achieves a 14.33% return, which is significantly higher than NCLEX's 0.43% return. Over the past 10 years, CSMCX has outperformed NCLEX with an annualized return of 16.31%, while NCLEX has yielded a comparatively lower 7.68% annualized return.
CSMCX
- 1D
- -0.20%
- 1M
- -4.47%
- 6M
- 6.88%
- YTD
- 14.33%
- 1Y
- 18.96%
- 3Y*
- 13.15%
- 5Y*
- 7.85%
- 10Y*
- 16.31%
- ALL TIME*
- 12.26%
NCLEX
- 1D
- 0.43%
- 1M
- 0.63%
- 6M
- 0.12%
- YTD
- 0.43%
- 1Y
- -1.86%
- 3Y*
- 0.61%
- 5Y*
- -0.53%
- 10Y*
- 7.68%
- ALL TIME*
- 9.16%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $0.00 | $0.00 | $0.00 | |
| $0.00 | $0.00 | $0.00 |
CSMCX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CSMCX Congress Small Cap Growth Fund | 14.33% | 8.37% | 18.65% | 20.27% | -26.21% | 39.30% | 39.11% | 36.12% | 2.51% | 22.58% |
NCLEX Nicholas Limited Edition Fund | 0.43% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
Correlation
The correlation between CSMCX and NCLEX is 0.70, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.70 |
Correlation (3Y) Balances recent behavior with more history. | 0.84 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.89 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.90 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 1999 | 0.90 |
Over the past year, the correlation between CSMCX and NCLEX has dropped to 0.70 - well below their long-term average of 0.90, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CSMCX vs. NCLEX — Risk / Return Rank
CSMCX
NCLEX
CSMCX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Congress Small Cap Growth Fund (CSMCX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CSMCX | NCLEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.01 | ||
| Sortino ratioReturn per unit of downside risk | +1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.98 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.31 | -0.16 | +1.47 |
| Martin ratioReturn relative to average drawdown | 4.06 | -0.32 | +4.38 |
Loading charts...
Drawdowns
CSMCX vs. NCLEX - Drawdown Comparison
The maximum CSMCX drawdown since its inception was -56.20%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for CSMCX and NCLEX.
Loading charts...
Drawdown Indicators
| CSMCX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.20% | -48.68% | -7.52% |
Max Drawdown (1Y)Largest decline over 1 year | -13.63% | -20.88% | +7.25% |
Max Drawdown (3Y)Largest decline over 3 years | -26.10% | -28.50% | +2.40% |
Max Drawdown (5Y)Largest decline over 5 years | -33.44% | -28.50% | -4.94% |
Max Drawdown (10Y)Largest decline over 10 years | -33.44% | -35.79% | +2.35% |
Current DrawdownCurrent decline from peak | -5.44% | -15.98% | +10.54% |
Average DrawdownAverage peak-to-trough decline | -9.35% | -8.32% | -1.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.39% | 10.65% | -6.26% |
Volatility
CSMCX vs. NCLEX - Volatility Comparison
Congress Small Cap Growth Fund (CSMCX) has a higher volatility of 5.52% compared to Nicholas Limited Edition Fund (NCLEX) at 4.95%. This indicates that CSMCX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CSMCX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.52% | 4.95% | +0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 16.34% | 12.76% | +3.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.99% | 17.31% | +4.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.72% | 19.62% | +3.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.44% | 19.22% | +3.22% |
CSMCX vs. NCLEX - Expense Ratio Comparison
CSMCX has a 1.00% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Dividends
CSMCX vs. NCLEX - Dividend Comparison
CSMCX's dividend yield for the trailing twelve months is around 2.05%, less than NCLEX's 7.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSMCX Congress Small Cap Growth Fund | 2.05% | 2.34% | 0.00% | 0.00% | 0.00% | 15.57% | 7.05% | 16.14% | 10.04% | 11.48% | 0.00% | 27.40% |
NCLEX Nicholas Limited Edition Fund | 7.50% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
CSMCX and NCLEX have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CSMCX has higher volatility (5.52%) compared to NCLEX (4.95%). In terms of maximum drawdown, CSMCX dropped -56.20% vs NCLEX's -48.68%.
CSMCX currently has the higher Sharpe Ratio (0.81 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CSMCX and NCLEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer